Credo Life Science
Posted on 27th January 2022
Pancreatin Pellets Manufacturer: What to Look for Before You Partner
Pancreatin, a mixture of digestive enzymes used to treat pancreatic insufficiency, is notoriously difficult to formulate into stable pellets due to its extreme sensitivity to moisture. Choosing the right manufacturing partner is critical to product success.
Why Pancreatin Pellets Are Uniquely Challenging
Unlike most APIs, pancreatin cannot tolerate water-based processing because moisture degrades the enzyme’s activity. Manufacturers must rely on carefully controlled non-aqueous processes and enteric coatings that protect the enzyme from stomach acid while preserving its potency until release in the intestine.
Essential Manufacturing Capabilities
A qualified pancreatin pellets manufacturer needs specialized fluid-bed processing experience, enteric coating expertise capable of preserving enzyme activity, and analytical testing methods specifically validated for enzyme potency rather than standard assay techniques alone.
Regulatory and Quality Considerations
WHO-GMP certification and DMF documentation remain essential baseline requirements, but for pancreatin specifically, ask for evidence of stability data demonstrating enzyme activity retention over the product’s intended shelf life under real-world storage conditions.
What to Ask a Prospective Partner
Request details on their moisture-control processes, their experience with enteric-coated enzyme formulations specifically, and examples of successful scale-up from pilot to commercial batches without loss of enzymatic potency.
The Value of Molecule-Specific Experience
Because pancreatin behaves so differently from typical small-molecule APIs, general pellet manufacturing experience alone isn’t a reliable predictor of success. Prioritize manufacturers who can point to direct, documented experience with pancreatin or closely comparable enzyme-based formulations.
Credo Life Sciences: Pancreatin EC Pellets in the Pipeline
Credo Life Sciences, incorporated in 2014 in Hyderabad, includes Pancreatin EC Pellets within its active R&D pipeline, reflecting the kind of specialized formulation focus this molecule demands. The company’s WHO-GMP certified facilities, DMF documentation aligned with USFDA, EU, and WHO-GMP standards, and broader EC pellet technology platform position it to address the specific challenges pancreatin formulation presents.
Conclusion: Partnering with a pancreatin pellets manufacturer requires verifying specialized moisture-control and enteric-coating expertise — not just general pellet manufacturing capability.